Showing 12,441 - 12,460 results of 102,654 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.37s Refine Results
  1. 12441
  2. 12442
  3. 12443
  4. 12444
  5. 12445
  6. 12446
  7. 12447
  8. 12448
  9. 12449
  10. 12450
  11. 12451
  12. 12452

    Competitive Arsenate and Phosphate Adsorption on Ferrihydrite as Described by the CD-MUSIC Model by Jon Petter Gustafsson (1851535)

    Published 2022
    “…This causes a flatter adsorption isotherm for As­(V), which leads to a stronger As­(V) adsorption as the As­(V)-to-Fe ratio decreases, compared to that for PO<sub>4</sub>.…”
  13. 12453

    DataSheet_1_Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzhe... by Eleni Fella (3925409)

    Published 2022
    “…We have previously administered the modified C5a receptor agonist (EP67) for a short period to a transgenic mouse model of AD (5XFAD) and have observed not only reduction in β-amyloid deposition and gliosis but also improvement in cognitive impairment. …”
  14. 12454
  15. 12455
  16. 12456
  17. 12457

    Identification of small molecules that inhibit viral M mRNA nuclear export and/or decrease viral M mRNA levels. by Matthew Esparza (8661219)

    Published 2020
    “…<p>(<b>A</b>) Representative images showing uninfected cells; cells infected with A/WSN/33 and pretreated with 0.5% DMSO (control), which show viral M mRNA exported into the cytoplasm, in red; and cells infected with A/WSN/33 pre-treated with 2.5 μM of the transcription inhibitor DRB (5,6-dichloro-1-β-D-ribofuranosylbenzimidazole). …”
  18. 12458

    Discovery of Oral AMP-Activated Protein Kinase Activators for Treating Hyperlipidemia by Mingchao Wang (450503)

    Published 2024
    “…A single dose of V1 (2000 mg) increased AMPK activation in human erythrocytes after 5 and 12 h of treatment. …”
  19. 12459
  20. 12460